Senior citizens and the burden of prescription drug outlaysWhat lessons for the medicare prescription drug benefit?

被引:2
|
作者
Panos Kanavos
Marin Gemmill
机构
[1] LSE Health and Social Care,London School of Economics and Political Science
关键词
Prescription Drug; Drug Expenditure; Private Health Insurance; Medical Expenditure Panel Survey; Federal Poverty Level;
D O I
10.2165/00148365-200403040-00005
中图分类号
学科分类号
摘要
This article uses data from a cohort of elderly and retired persons over the 1996–2001 period in the US to (i) determine the extent to which changes in socioeconomic or demographic characteristics, particularly age, income and education, impact the total amount that is spent on prescription drugs and (ii) to analyse the predictors of individual out-of-pocket (OOP) prescription drug outlays among the same cohort and determine whether age, race, sex, income, education, marital status and health status have an influence on these. The analysis considers the implications for elderly individuals who choose to participate in the new Medicare Part D drug benefit, labelled the Medicare Prescription Drug, Improvement, and Modernisation Act of 2003. The results highlight the necessity for the Medicare prescription drug benefit to carefully target the eldest among the elderly, who are most in need and are in danger of becoming trapped in the so-called Medicare ‘doughnut hole’, i.e. incur high prescription drug outlays, without adequate coverage. The study also finds evidence that women, those who are not married, middle income elderly and those in poor health, who purchase drugs more intensively, are at risk of incurring significant prescription OOP drug outlays.
引用
收藏
页码:217 / 227
页数:10
相关论文
共 50 条
  • [31] The impact of the medicare part D prescription drug benefit on prescription utilization and out-of-pocket expenditures
    Yin, W.
    Basu, A.
    Zhang, J.
    Rabbani, A.
    Meltzer, D.
    Alexander, G.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2008, 56 (03) : 620 - 620
  • [32] Medicare prescription drug statement of principles
    Emmer, S
    Gorbien, M
    Ranno, A
    Potter, J
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2000, 48 (10) : 1337 - 1337
  • [33] The impact of Medicare part D prescription drug benefit program on generic drug prescription A study in long-term care facilities
    Jung, Changmi
    Padman, Rema
    Anwar, Shamena
    MEDICINE, 2019, 98 (32)
  • [34] Medicare prescription drug coverage: A very long wait for a very modest benefit
    Dalen, JE
    Hartz, DJ
    AMERICAN JOURNAL OF MEDICINE, 2005, 118 (04): : 325 - 329
  • [35] How Much Choice Is Too Much? The Case of the Medicare Prescription Drug Benefit
    Hanoch, Yaniv
    Rice, Thomas
    Cummings, Janet
    Wood, Stacey
    HEALTH SERVICES RESEARCH, 2009, 44 (04) : 1157 - 1168
  • [37] President Bush and social policy: The strange case of the medicare prescription drug benefit
    Jaenicke, Douglas
    Waddan, Alex
    POLITICAL SCIENCE QUARTERLY, 2006, 121 (02) : 217 - 240
  • [38] Differential take-up of the medicare part D prescription drug benefit
    Rabbani, A.
    Yin, W.
    Zhang, J. X.
    Sun, S.
    Alexander, G. C.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2008, 23 : 282 - 282
  • [39] Differential take-up of the medicare part D prescription drug benefit
    Rabbani, A.
    Yin, W.
    Zhang, J. X.
    Sun, S. X.
    Alexander, G. C.
    VALUE IN HEALTH, 2008, 11 (03) : A12 - A13
  • [40] Adverse Selection In The Medicare Prescription Drug Program
    Riley, Gerald F.
    Levy, Jesse M.
    Montgomery, Melissa A.
    HEALTH AFFAIRS, 2009, 28 (06) : 1826 - 1837